» Articles » PMID: 30103835

Is Vaccinating Monkeys Against Yellow Fever the Ultimate Solution for the Brazilian Recurrent Epizootics?

Overview
Date 2018 Aug 15
PMID 30103835
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccinating monkeys against yellow fever (YF) has been a common practice in the beginning of the 17D vaccine development. Although it may seem strange at first sight, vaccinating monkeys as a public health strategy is, we think, feasible and theoretically could eliminate the infection among non-human primates, interrupting the virus circulation (or significantly reducing it) and therefore reducing the risk of spilling over to the human population. We propose a series of studies that could demonstrate (or not) the efficacy and feasibility of vaccinating non-human primates YF reservoirs living in green areas of urban centres to cut off or curb the virus circulation that recurrently spill over to the human population. Therefore, vaccinating monkeys in relatively small green areas of the urban centres is perhaps the ultimate solution for the Brazilian recurrent YF epizootics.

Citing Articles

Neotropical Sylvatic Mosquitoes and Are Not Competent to Transmit 17DD Attenuated Yellow Fever Virus from Vaccinated Viremic New World Non-Human Primates.

de Miranda R, Fernandes R, da Silva-Fernandes A, Ferreira-de-Brito A, Moreira S, Pereira R Viruses. 2022; 14(10).

PMID: 36298786 PMC: 9611963. DOI: 10.3390/v14102231.


Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects.

Gianchecchi E, Cianchi V, Torelli A, Montomoli E Vaccines (Basel). 2022; 10(3).

PMID: 35335004 PMC: 8955180. DOI: 10.3390/vaccines10030372.


Re-emergence of yellow fever in the neotropics - quo vadis?.

Sacchetto L, P Drumond B, Han B, Nogueira M, Vasilakis N Emerg Top Life Sci. 2020; 4(4):399-410.

PMID: 33258924 PMC: 7733675. DOI: 10.1042/ETLS20200187.


Yellow fever control: current epidemiology and vaccination strategies.

Chen L, Wilson M Trop Dis Travel Med Vaccines. 2020; 6:1.

PMID: 31938550 PMC: 6954598. DOI: 10.1186/s40794-020-0101-0.

References
1.
Massad E, Amaku M, Coutinho F, Struchiner C, Lopez L, Coelho G . The risk of urban yellow fever resurgence in Aedes-infested American cities. Epidemiol Infect. 2018; 146(10):1219-1225. PMC: 9134282. DOI: 10.1017/S0950268818001334. View

2.
Moreno E, Spinola R, Tengan C, Brasil R, Siciliano M, Coimbra T . Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009. Rev Inst Med Trop Sao Paulo. 2013; 55(1):45-50. DOI: 10.1590/s0036-46652013000100008. View

3.
Massad E, Amaku M, Coutinho F, Struchiner C, Lopez L, Wilder-Smith A . Estimating the size of populations from dengue incidence data: Implications for the risk of yellow fever outbreaks. Infect Dis Model. 2018; 2(4):441-454. PMC: 6002028. DOI: 10.1016/j.idm.2017.12.001. View

4.
Pinto L, Costa C, Strier K, da Fonseca G . Habitat, density and group size of primates in a Brazilian tropical forest. Folia Primatol (Basel). 1993; 61(3):135-43. DOI: 10.1159/000156740. View

5.
Schlesinger J, Brandriss M, Cropp C, Monath T . Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol. 1986; 60(3):1153-5. PMC: 253373. DOI: 10.1128/JVI.60.3.1153-1155.1986. View